News Channels

13 Jun 2017 Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association
13 Jun 2017 ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
13 Jun 2017 Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
13 Jun 2017 Autoantigen GAD-Vaccine is Safe for Children at High Risk for Developing Type 1 Diabetes
13 Jun 2017 INVOKANA® (canagliflozin) Significantly Reduces the Combined Risk of Cardiovascular Death, Myocardial Infarction and Stroke in the CANVAS Program
13 Jun 2017 Tresiba® demonstrated no increased risk of major cardiovascular events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial
12 Jun 2017 PeptiDream Announces Licensing of Peptide Discovery Platform System (PDPS) Technology to Shionogi
12 Jun 2017 Alkermes Announces Initiation of Study 217 for ALKS 5461 for Treatment of Major Depressive Disorder
12 Jun 2017 Drug Candidates Developed Using Zymeworks’ Azymetric Platform Nominated for Late-Stage, Preclinical Development by Lilly
12 Jun 2017 Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%
12 Jun 2017 Bioverativ Announces FDA Acceptance of Investigational New Drug Application for BIVV001 to Treat Hemophilia A
12 Jun 2017 Seres Therapeutics Initiates SER-109 Phase 3 Study in Patients with Multiply Recurrent C. difficile Infection
12 Jun 2017 CARMA Therapeutics Closes Initial Funding to Advance Chimeric Antigen Receptor Macrophages (CARMA) to Treat Solid Tumors
12 Jun 2017 Exelixis Announces Initiation of Phase 1b Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors
12 Jun 2017 Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for HIV Treatment
12 Jun 2017 Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery
12 Jun 2017 Regulus Announces Pipeline Updates and Advancements
12 Jun 2017 Jardiance® (empagliflozin) tablets to be studied in chronic kidney disease
12 Jun 2017 Dragonfly Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel Natural Killer (NK) Cell-Based Immunotherapies using Dragonfly's TriNKET™ technology platform
12 Jun 2017 Zealand to regain control of elsiglutide

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top